N-Acetyl Semax Amidate vs Semax: What’s the Difference?
Both molecules start with the same seven-amino-acid backbone, yet only Semax is named in FDA’s October 2026 interim policy that lets certain peptides be compounded while regulators collect more safety data.
Semax is a synthetic seven-amino-acid fragment of the adrenocorticotropic hormone (ACTH 4-7) with an added Pro-Gly-Pro tail; N-acetyl Semax amidate starts from the same sequence but caps it with an N-terminal acetyl group and a C-terminal amide. The tweaks add 41 daltons to the molecular weight and may slow enzymatic breakdown, yet there is no head-to-head human research proving the modified version works better-or at all. Importantly, FDA’s October 2026 interim enforcement discretion policy lists Semax, not N-acetyl Semax amidate, meaning the original can be compounded by state-licensed 503A pharmacies under the policy, while the acetyl-amidate variant remains outside it.
- Semax’s molecular formula is C37H51N9O10S and its molecular weight is 813.93 g/mol (fda.gov).
- N-acetyl Semax amidate adds an acetyl cap and an amide tail, bringing the formula to C39H54N10O10S with a listed weight of 854.98 g/mol (PubChem).
- Only Semax is named in FDA’s interim “Access Policy for Compounding Using Certain Peptides,” so compounders may legally prepare it for individual patients under that policy; the acetyl-amidate form is excluded.
- Human evidence for either peptide is sparse and includes small, short-term studies on stroke recovery, cognitive fatigue and neuropathic pain; no large-scale randomized trials verify efficacy.
- Rx.com plans to offer prescription compounded versions of Semax and other covered peptides through U.S.-licensed providers and a 503A pharmacy (coming soon).
What Semax and N-acetyl Semax amidate are
Semax is a synthetic heptapeptide-Met-Glu-His-Phe-Pro-Gly-Pro-derived from the ACTH 4-7 fragment and modified with an extra Pro-Gly-Pro tail to resist rapid degradation. It is not FDA-approved for any medical use in the United States (fda.gov).
N-acetyl Semax amidate (often abbreviated NA-Semax-NH2) keeps the same seven amino acids but “caps” the N-terminus with an acetyl group and converts the free acid at the C-terminus into an amide. Both caps are common medicinal-chemistry tricks to make peptides less susceptible to peptidases in blood and gut fluids, potentially lengthening half-life.
| Structural comparison | |
|---|---|
| Backbone sequence | Met-Glu-His-Phe-Pro-Gly-Pro (both) |
| N-terminal group | Free amine (Semax) vs Acetyl (NA Semax Amidate) |
| C-terminal group | Free acid (Semax) vs Primary amide (NA Semax Amidate) |
| Molecular formula | C37H51N9O10S vs C39H54N10O10S |
| Molecular weight | 813.93 g/mol vs 854.98 g/mol |
How the structural tweaks may change the peptide
N-terminal acetylation: Adding an acetyl group blocks the positive charge of the terminal amine, which can reduce recognition by aminopeptidases that chop from the N-end. In theory this can lengthen plasma half-life, but no published human pharmacokinetic data confirm a longer half-life for NA-Semax-NH2.
C-terminal amidation: Converting the terminal carboxylic acid to a neutral amide removes the negative charge at physiologic pH and can improve membrane permeability. Again, no human trials have measured whether the amidated form crosses the blood-brain barrier better than Semax.
Net effect on receptor activity: Both peptides retain the ACTH 4-7 core that is thought to interact with melanocortin receptors, but binding studies comparing the two molecules side-by-side have not been published.
| Proposed advantage | Evidence available | Conclusion |
|---|---|---|
| Longer half-life | No human PK study found | Unproven |
| Greater brain penetration | Only rodent tracer data, not replicated | Unproven |
| Stronger cognitive effect | No head-to-head clinical trial | Unknown |
Claims vs evidence: what the science actually shows
Small Russian studies of Semax from the 1990s reported improved recovery after ischemic stroke and relief of tension-type headaches, but the studies were small and most lacked placebo controls. The data have not undergone FDA review or large-scale replication.
N-acetyl Semax amidate has virtually no human data. Online sellers cite animal studies that measured learning or nerve-growth-factor release, but no peer-reviewed human trials have been published. In other words, the acetyl-amidate form’s benefits remain theoretical.
⚠️ Evidence gap
Neither peptide has Phase 3 clinical trials. Patients should view all benefit claims as unproven until high-quality human studies are completed.
Policy status: why only Semax is covered
October 2026 interim enforcement discretion: The Department of Health & Human Services and FDA announced that they “do not intend to take enforcement action” against state-licensed 503A compounding pharmacies that compound six specific peptides-including Semax-for individual patients who have a valid prescription, provided quality and safety conditions are met. The policy is interim, has no set end date, and may change if safety problems emerge.
N-acetyl Semax amidate is not named. Because the acetyl-amidate variant is a distinct chemical entity, it falls outside the text of the policy. A pharmacy that compounds it could face FDA action unless the agency later amends the peptide list.
Readers can learn more about how FDA selects bulk drug substances in our bulks-list explainer and review the policy details in our policy deep dive.
Access options for prescription compounded Semax
Rx.com plans to offer prescription compounded versions of Semax through U.S.-licensed providers and a state-licensed 503A pharmacy (coming soon). The service will require a confidential online health intake, and the provider will decide whether Semax is appropriate for the individual patient.
Once available, qualified patients will be able to start the prescription process at prescription peptides from Rx.com. Because the policy excludes N-acetyl Semax amidate, Rx.com will not offer that molecule unless FDA adds it to a future list.
No over-the-counter option: Retail “research use only” vials of NA-Semax-NH2 are not regulated for human quality or sterility. Purchasing such products bypasses medical oversight and falls outside the FDA policy entirely.
Should you ask your provider about Semax?
Check the column that fits your situation:
✅ Might be reasonable to discuss
- You have debilitating post-stroke fatigue or cognitive fog that standard therapy has not improved
- You are willing to use an unapproved peptide under close medical supervision
- You understand benefits are unproven and agree to report side effects promptly
- No history of allergy to peptide preparations
🏥 See a doctor-not a peptide vial
- You have uncontrolled hypertension, heart failure or a recent heart attack
- You are pregnant, trying to conceive or breastfeeding (safety unknown)
- You have active cancer or a history of melanoma (peptide growth effects uncertain)
- You take anticoagulants or immunosuppressants (unknown interactions)
Safety, side effects and unknowns
Most reported side effects are mild and include temporary nasal irritation (for spray formats), headache, jitteriness or insomnia. Because large studies are lacking, less common but serious risks may be undiscovered.
No long-term safety data: The longest Semax study in humans publicly available followed stroke patients for eight weeks, far short of the months or years that some users take the peptide. NA-Semax-NH2 has no published human safety data at all.
Drug interactions are theoretical. Semax modulates melanocortin receptors and may influence catecholamine release. Until interaction studies are done, caution is advised if you use antidepressants, stimulants or blood-pressure medications.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe headache or sudden vision changes: could signal dangerously high blood pressure or bleeding in the brain
- Chest pain, palpitations or fainting: heart rhythm effects are unknown and need urgent evaluation
- New or worsening anxiety, agitation or insomnia: may indicate central nervous system overstimulation
- Allergic reaction such as rash, swelling of the tongue or difficulty breathing
- Unexplained bruising or bleeding: potential platelet or coagulation effects are not studied
- Dark or changing skin lesions: melanocortin activity raises theoretical melanoma concerns
- Thoughts of self-harm or suicidal ideation: call or text the 988 Suicide & Crisis Lifeline, then seek emergency care
Scientific References
Frequently Asked Questions
Is N-acetyl Semax amidate legal to buy in the United States?
It is legal to purchase as a “research use only” chemical, but that label means it is not regulated for human administration. Compounding pharmacies cannot rely on FDA’s interim policy to dispense it because the policy lists only Semax, not the acetyl-amidate form.
Does N-acetyl Semax amidate last longer in the body than Semax?
Theoretically the acetyl and amide caps slow enzymatic breakdown, yet no human pharmacokinetic study has been published to confirm a longer half-life. Any claimed duration advantage remains speculative.
Can I switch from NA-Semax-NH2 to prescription Semax?
If FDA’s interim policy conditions are met, a licensed provider can prescribe compounded Semax for you. Because the two molecules are different, your provider will need to review your history rather than treating them as interchangeable.
Are there any FDA-approved drugs that contain Semax?
No. Semax has never completed the FDA drug-approval process. The interim enforcement discretion allows compounding but does not constitute approval.
Does Semax improve ADHD or memory in healthy people?
No robust human data support those uses. Most existing studies are in post-stroke or cognitive-fatigue settings, and even there the evidence is preliminary.
Will Rx.com sell N-acetyl Semax amidate in the future?
Not unless FDA expands its peptide list or approves the molecule. Rx.com plans to offer only those peptides included in the enforcement-discretion policy, compounded for patients with a valid prescription.
Can I take Semax with antidepressants?
No interaction studies exist. Because both may influence brain monoamines, combining them should be done only under a provider’s supervision, if at all.
How do I start the prescription process for Semax once Rx.com launches it?
When available, you will complete a secure online health intake at Rx.com. A U.S.-licensed provider will review your information and decide whether Semax is appropriate. If they prescribe it, the medication will be compounded at a 503A pharmacy and shipped to your door.
